Skip to main content
Clinical Trials/NCT04252729
NCT04252729CompletedNot Applicable

Effect of Psychotherapy on Quality of Life and Recurrence of Events in Patients With Recurrent Vasovagal Syncope: A Randomized Pilot Study

Mauricio Ibrahim Scanavacca2 sites in 1 country10 target enrollmentStarted: July 27, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
10
Locations
2
Primary Endpoint
Quality of life analysis performed by the Short Form 36 Instrument

Study Overview

Brief Summary

Recurrent vasovagal syncope although presenting a benign prognosis in terms of survival, is associated with significant impairment of quality of life. The impaired emotional status is also related to the recurrence of the events, closing a negative cycle for the evolution of the disease. This study aims to evaluate the effect of psychotherapy on the quality of life and in the number of syncope and pre-syncope events during one year of follow-up of patients with recurrent vasovagal syncope.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of vasovagal syncope with positive TILT TEST and recurrent episodes (≥2 episode within 6 months)
  • Signed Free and Informed Consent Form

Exclusion Criteria

  • Severe comorbidity with life expectancy <1 year
  • Age <18 years
  • Current psychotherapeutic follow-up
  • Cardiac or neurological syncope
  • Pregnancy

Outcomes

Primary Outcomes

Quality of life analysis performed by the Short Form 36 Instrument

Time Frame: 12 months

Data collected at 12 months (global assessment and by specific domains).

Secondary Outcomes

  • Number of comorbidities(12 months)
  • Use of concomitant medication(12 months)
  • Demographic data(12 months)

Investigators

Sponsor
Mauricio Ibrahim Scanavacca
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Mauricio Ibrahim Scanavacca

Arrhythmia Clinical Unit Director

University of Sao Paulo General Hospital

Study Sites (2)

Loading locations...

Similar Trials